87 related articles for article (PubMed ID: 35654940)
1. Post-vaccination outcomes in association with four COVID-19 vaccines in the Kingdom of Bahrain.
AlQahtani M; Du X; Bhattacharyya S; Alawadi A; Al Mahmeed H; Al Sayed J; Justman J; El-Sadr WM; Hidary J; Mukherjee S
Sci Rep; 2022 Jun; 12(1):9236. PubMed ID: 35654940
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study).
Vokó Z; Kiss Z; Surján G; Surján O; Barcza Z; Wittmann I; Molnár GA; Nagy D; Müller V; Bogos K; Nagy P; Kenessey I; Wéber A; Polivka L; Pálosi M; Szlávik J; Rokszin G; Müller C; Szekanecz Z; Kásler M
Front Immunol; 2022; 13():919408. PubMed ID: 35935993
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of ChAdOx1 nCoV-19 and BBIBP-CorV vaccines against COVID-19-associated hospitalisation and death in the Seychelles infected adult population.
Theresa Pool SN; Shroff EH; Chetty A; Lewis L; Nonhlanhla YZ; Abdool Karim SS
PLoS One; 2024; 19(4):e0299747. PubMed ID: 38578809
[TBL] [Abstract][Full Text] [Related]
4. Comparison of T cells mediated immunity and side effects of mRNA vaccine and conventional COVID-19 vaccines administrated in Jordan.
Jaber HM; Ebdah S; Al Haj Mahmoud SA; Abu-Qatouseh L; Jaber YH
Hum Vaccin Immunother; 2024 Dec; 20(1):2333104. PubMed ID: 38584118
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study).
Molnár GA; Vokó Z; Sütő G; Rokszin G; Nagy D; Surján G; Surján O; Nagy P; Kenessey I; Wéber A; Pálosi M; Müller C; Kásler M; Wittmann I; Kiss Z
BMJ Open Diabetes Res Care; 2024 Jan; 12(1):. PubMed ID: 38267204
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of the SARS-CoV-2 Vaccination in Preventing Severe Disease-Related Outcomes: A Population-Based Study in the Italian Province of Bolzano (South Tyrol).
Lorenzon A; Palandri L; Uguzzoni F; Cristofor CD; Lozza F; Poluzzi R; Rizzi C; Bertoli P; Zerzer F; Righi E
Int J Public Health; 2024; 69():1606792. PubMed ID: 38550269
[No Abstract] [Full Text] [Related]
7. Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina.
González S; Olszevicki S; Salazar M; Calabria A; Regairaz L; Marín L; Campos P; Varela T; Martínez VVG; Ceriani L; Garcia E; Kreplak N; Pifano M; Estenssoro E; Marsico F
EClinicalMedicine; 2021 Oct; 40():101126. PubMed ID: 34541480
[TBL] [Abstract][Full Text] [Related]
8. Comparative Analysis of SARS-CoV-2 Antibody Responses across Global and Lesser-Studied Vaccines.
Zambrana JV; Saenz C; Maier HE; Brenes M; Nuñez A; Matamoros A; Hernández M; Dumas K; Toledo C; Peralta L; Gordon A; Balmaseda A
Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543960
[TBL] [Abstract][Full Text] [Related]
9. Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers.
Alqassieh R; Suleiman A; Abu-Halaweh S; Santarisi A; Shatnawi O; Shdaifat L; Tarifi A; Al-Tamimi M; Al-Shudifat AE; Alsmadi H; Al Sharqawi A; Alnawaiseh H; Anasweh Y; Domaidah FA; Jaber HA; Al-Zarir MR; Bsisu I
Vaccines (Basel); 2021 Oct; 9(11):. PubMed ID: 34835153
[TBL] [Abstract][Full Text] [Related]
10. Observations of COVID-19 vaccine coverage and vaccine hesitancy on COVID-19 outbreak: An American ecological study.
Bajracharya D; Jansen RJ
Vaccine; 2024 Jan; 42(2):246-254. PubMed ID: 38103963
[TBL] [Abstract][Full Text] [Related]
11. Hospitalisations and Deaths Averted by COVID-19 Vaccination in Navarre, Spain, 2021-2022.
Martínez-Baz I; Trobajo-Sanmartín C; Miqueleiz A; Egüés N; García Cenoz M; Casado I; Navascués A; Fernández-Huerta M; Echeverría A; Guevara M; Ezpeleta C; Castilla J
Vaccines (Basel); 2024 Jan; 12(1):. PubMed ID: 38250871
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness Analysis of Vaccines for COVID-19 According to Sex, Comorbidity and Socioeconomic Status: A Population Study.
Mar J; Ibarrondo O; Estadilla CDS; Stollenwerk N; Antoñanzas F; Blasco-Aguado R; Larrañaga I; Bidaurrazaga J; Aguiar M
Pharmacoeconomics; 2024 Feb; 42(2):219-229. PubMed ID: 37910377
[TBL] [Abstract][Full Text] [Related]
13. Association between vaccination rates and COVID-19 health outcomes in the United States: a population-level statistical analysis.
Du H; Saiyed S; Gardner LM
BMC Public Health; 2024 Jan; 24(1):220. PubMed ID: 38238709
[TBL] [Abstract][Full Text] [Related]
14. Impact of COVID-19 vaccination: a global perspective.
Singh P; Anand A; Rana S; Kumar A; Goel P; Kumar S; Gouda KC; Singh H
Front Public Health; 2023; 11():1272961. PubMed ID: 38274537
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the Delta Variant B.1.617.2 COVID-19.
Shiehzadegan S; Alaghemand N; Fox M; Venketaraman V
Clin Pract; 2021 Oct; 11(4):778-784. PubMed ID: 34698149
[TBL] [Abstract][Full Text] [Related]
16. Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational Data.
Hulme WJ; Williamson E; Horne EMF; Green A; McDonald HI; Walker AJ; Curtis HJ; Morton CE; MacKenna B; Croker R; Mehrkar A; Bacon S; Evans D; Inglesby P; Davy S; Bhaskaran K; Schultze A; Rentsch CT; Tomlinson L; Douglas IJ; Evans SJW; Smeeth L; Palmer T; Goldacre B; Hernán MA; Sterne JAC
Ann Intern Med; 2023 May; 176(5):685-693. PubMed ID: 37126810
[TBL] [Abstract][Full Text] [Related]
17. Delta Variant in the COVID-19 Pandemic: A Comparative Study on Clinical Outcomes Based on Vaccination Status.
Vulturar DM; Moacă LȘ; Neag MA; Mitre AO; Alexescu TG; Gherman D; Făgărășan I; Chețan IM; Gherman CD; Melinte OE; Trofor AC; Todea DA
J Pers Med; 2024 Mar; 14(4):. PubMed ID: 38672984
[TBL] [Abstract][Full Text] [Related]
18. A Narrative Review of the Coronavirus Disease 2019 Response in the Kingdom of Bahrain.
AlQahtani M; Jawad JS; AlAwadhi A; Saffar BMA; AlAlawi EF; Adnan HHS; Haridy H; Joury J; Del Carmen Morales G
Curr Ther Res Clin Exp; 2024; 100():100733. PubMed ID: 38947880
[TBL] [Abstract][Full Text] [Related]
19. Evaluating targeted COVID-19 vaccination strategies with agent-based modeling.
Hladish TJ; Pillai AN; Pearson CAB; Toh KB; Tamayo A; Stoltzfus A; Longini IM
medRxiv; 2023 Mar; ():. PubMed ID: 36945423
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum to "Comparison of Astra Zeneca and sinopharm vaccines as boosters in protection against COVID-19 infection" [Biologicals 82 (2023) 101668].
Letafati A; Eyvazzadeh N; Gharehkhani A; Khorshidian A; Chalabiani S; Soufiani EK; Khakpoor N; Shamsodini B; Beheshti T; Bavili Olyaei RT; Soleimani A; Melyani F; Hossein GM
Biologicals; 2023 Nov; 84():101719. PubMed ID: 37866229
[No Abstract] [Full Text] [Related]
[Next] [New Search]
